Skip to main content
. 2016 Jan 5;18(3):203–216. doi: 10.1111/dom.12591

Figure 3.

DOM-12591-FIG-0003-c

The chemically distinct structures of dipeptidyl peptidase 4 (DPP‐4) inhibitors [(A–E) for DPP‐4 inhibitors indicates order of approval] and GLP‐1RAs. Images (A–E) © of Wiley and reproduced with permission from Deacon et al., Diabetes Obes Metab 2011; 13: 7–18; Drucker and Nauck. Lancet 2006; 368: 1696–705 [glucagon‐like peptide‐1 (GLP‐1), exenatide, liraglutide] 8, 27.